MT. KISCO, N.Y., June 6, 2013 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company has recorded sales growth of 30% in the first 6 months of 2013, as compared to the same period in 2012, in its cosmetic and anti-aging skin care segments.
Mark McLaughlin, President and CEO stated, "ImmuDyne sells essential active ingredients to some of the most reputable skin care and cosmetic companies in the world. Orders placed through June 5, 2013 total $445,000, up thirty percent from the first half of 2012. We are projecting year-end sales in this segment to be $1,000,000, a considerable increase over last year's sales. The increase in demand for our proprietary cosmetic and anti-aging skin care ingredients is a testimony to the quality and effectiveness of our products."
ImmuDyne's, proprietary topical formulation of beta-1,3/1,6-D-glucan, activates the Langerhans cells of the skin, naturally increasing cell renewal, skin firmness, volume, and reducing fine lines and wrinkles. Activated Langerhans cells heal microscopic wounds, fight against infection, and counteract damage caused by sun exposure, environmental toxins, and the natural aging process. In an 8-week clinical trial, participants had a significant increase in skin firmness and decrease in wrinkles, resulting in a younger appearance of 15 years of age.
Karen Kingston, Chief Marketing Officer commented, "It is great to see increasing demand for our cosmetic and anti-aging skin care products. This revenue growth will ensure that the Company surpasses our $1,000,000 2013 forecast, as well as meet or exceed our $17,000,000 sales projection set for 2014. We are also pleased to announce that we are ahead of schedule in regards to the launch of our proprietary product for peri-/post- alcohol consumption. The controlled market release and product experience program has been moved from August to June 14th of this year."
ImmuDyne is a health and wellness lifestyle company. ImmuDyne has a portfolio of unique patent-protected products with applications in the wellness lifestyle, skin care, anti-aging, fitness, and health markets. ImmuDyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, KY.
ImmuDyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com.
Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.
CONTACT: ImmuDyne, Inc. Mark McLaughlin +1-914-714-8901 MarkMcL@immudyne.comSource:ImmuDyne, Inc.